Uas Life Sciences India Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 03-12-2024
- Paid Up Capital ₹ 2.10 M
as on 03-12-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2016)
- Profit -27.29%
(FY 2016)
- Ebitda -27.46%
(FY 2016)
- Net Worth -130.05%
(FY 2016)
- Total Assets 5.70%
(FY 2016)
About Uas Life Sciences India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.10 M, as per Ministry of Corporate Affairs (MCA) records.
Richa Sharma and Krishnamohan Puvvada serve as directors at the Company.
- CIN/LLPIN
U51397TG2014FTC093664
- Company No.
093664
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
21 Mar 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Uas Life Sciences India Private Limited offer?
Uas Life Sciences India Private Limited offers a wide range of products and services, including Product Packing & Labelling Services, Packaging Solutions.
Who are the key members and board of directors at Uas Life Sciences India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Richa Sharma  | Director | 27-Jul-2020 | Current |
| Krishnamohan Puvvada | Additional Director | 04-Sep-2024 | Current |
Financial Performance and Corporate Structure Insights of Uas Life Sciences India.
Uas Life Sciences India Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 27.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 130.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uas Life Sciences India?
In 2017, Uas Life Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Synergia Life Sciences Private LimitedActive 20 years 8 monthsKrishnamohan Puvvada is a mutual person
Novozymes South Asia Private LimitedActive 26 years 4 monthsKrishnamohan Puvvada is a mutual person
_PRIVATE_LIMITED.webp)
Riata Life Sciences Private LimitedActive 11 years 11 monthsKrishnamohan Puvvada is a mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Uas Life Sciences India?
Unlock and access historical data on people associated with Uas Life Sciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uas Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uas Life Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
